Theravance Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 11/14/2025 | 9.51 M | $138.86 M | 0.00% | 18.96% |
| WEISS ASSET MANAGEMENT LP | 11/14/2025 | 7.46 M | $108.87 M | 0.00% | 14.86% |
| NEWTYN MANAGEMENT, LLC | 11/14/2025 | 4.95 M | $72.27 M | 0.00% | 9.87% |
| BLACKROCK, INC. | 11/12/2025 | 4.07 M | $59.41 M | -1.69% | 8.11% |
| IRENIC CAPITAL MANAGEMENT LP | 11/14/2025 | 2.76 M | $40.31 M | 0.00% | 5.50% |
| VANGUARD GROUP INC | 11/07/2025 | 2.21 M | $32.29 M | 2.51% | 4.41% |
| PARK WEST ASSET MANAGEMENT LLC | 11/14/2025 | 1.28 M | $18.75 M | -28.63% | 2.56% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.21 M | $17.66 M | 20.72% | 2.41% |
| OASIS MANAGEMENT CO LTD. | 11/14/2025 | 1.12 M | $16.34 M | 0.00% | 2.23% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 1.09 M | $15.90 M | 252.95% | 2.17% |
| STATE STREET CORP | 11/14/2025 | 1.06 M | $15.42 M | 1.96% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 897.99 K | $13.11 M | 0.45% | 1.79% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 766.70 K | $11.19 M | 6.18% | 1.53% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 726.78 K | $10.61 M | 100.00% | 1.45% |
| MORGAN STANLEY | 11/14/2025 | 599.55 K | $8.75 M | 8.89% | 1.19% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 527.11 K | $7.70 M | -2.32% | 1.05% |
| UBS GROUP AG | 11/13/2025 | 514.17 K | $7.51 M | 29.47% | 1.02% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 414.72 K | $6.05 M | 1,629.42% | 0.83% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 373.60 K | $5.45 M | -3.58% | 0.74% |
| MARSHALL WACE, LLP | 11/13/2025 | 357.65 K | $5.22 M | 254.89% | 0.71% |
| NORTHERN TRUST CORP | 11/14/2025 | 341.31 K | $4.98 M | -3.10% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 320.14 K | $4.67 M | 5.35% | 0.64% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 11/10/2025 | 310.70 K | $4.54 M | 100.00% | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 264.31 K | $3.86 M | 0.00% | 0.53% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 258.65 K | $3.78 M | 29.72% | 0.52% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 231.27 K | $3.38 M | 1,199.87% | 0.46% |
| JPMORGAN CHASE & CO | 11/26/2025 | 213.10 K | $3.11 M | 78.31% | 0.42% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 211.05 K | $3.08 M | 2.81% | 0.42% |
| MACQUARIE GROUP LTD | 11/13/2025 | 208.78 K | $3.05 M | 0.00% | 0.42% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 200.30 K | $2.92 M | 588.32% | 0.40% |
| ALGERT GLOBAL LLC | 11/14/2025 | 199.71 K | $2.92 M | 100.00% | 0.40% |
| JANE STREET GROUP, LLC | 11/14/2025 | 191.80 K | $2.80 M | 348.50% | 0.38% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 181.48 K | $2.65 M | 814.24% | 0.36% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 174.84 K | $2.55 M | 208.83% | 0.35% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 144.53 K | $2.11 M | -7.90% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 130.15 K | $1.90 M | -22.27% | 0.26% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 127.21 K | $1.86 M | 100.00% | 0.25% |
| BARCLAYS PLC | 11/12/2025 | 115.39 K | $1.68 M | -12.45% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 114.57 K | $1.67 M | 3.64% | 0.23% |
| PDT PARTNERS, LLC | 11/17/2025 | 109.71 K | $1.60 M | -8.82% | 0.22% |
| JANE STREET GROUP, LLC | 11/14/2025 | 101.10 K | $1.48 M | 100.00% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 95.73 K | $1.40 M | 4.62% | 0.19% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 92.43 K | $1.35 M | 158.11% | 0.18% |
| NUVEEN, LLC | 11/12/2025 | 92.21 K | $1.35 M | -23.53% | 0.18% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 92.18 K | $1.35 M | -33.18% | 0.18% |
| MAN GROUP PLC | 11/14/2025 | 79.79 K | $1.16 M | 100.00% | 0.16% |
| WINTON GROUP LTD | 11/13/2025 | 76.54 K | $1.12 M | 100.00% | 0.15% |
| INSPIRE INVESTING, LLC | 10/15/2025 | 73.56 K | $1.07 M | 100.00% | 0.15% |
| MARTINGALE ASSET MANAGEMENT L P | 11/13/2025 | 70.97 K | $1.04 M | 3.09% | 0.14% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 70.08 K | $1.02 M | 0.00% | 0.14% |
Theravance Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 217 institutional investors and hedge funds held shares of Theravance Biopharma, Inc.. The most heavily invested institutionals were:
Madison Avenue Partners, LP: 9.51 M
Weiss Asset Management LP: 7.46 M
Newtyn Management, LLC: 4.95 M
BlackRock, Inc.: 4.07 M
Irenic Capital Management LP: 2.76 M
VANGUARD GROUP INC: 2.21 M
96.43% of Theravance Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 76.30 M shares in the last 24 months. This purchase volume represents approximately $1.10 B in transactions.